Optometry Times now breaks news on Facebook, Twitter

Article

Optometry Times, the leading source of optometric news, has established a presence on Twitter at https://twitter.com/#!/OptometryTimes and Facebook at www.facebook.com/#!/OptometryTimes.

North Olmstead, OH-Optometry Times, the leading source of optometric news, has established a presence on Twitter at https://twitter.com/#!/OptometryTimes and Facebook at www.facebook.com/#!/OptometryTimes.

 “We’ve found there is so much happening in optometry and in the ophthalmic industry that we could not keep up with all of it with a print publication, Web site, and e-newsletter,” said Rich Kirkner, editor-in-chief of Optometry Times.

“Social media is giving us an opportunity to push out more news that’s meaningful to optometrists more frequently than we could otherwise,” Kirkner said.

Among the breaking news Optometry Times has already reported in the social media space are a nutshell explanation of why the debate over vision plans and health insurance exchanges is heating up; the death of optometric visionary Irvin M. Borish, OD, LLD, FAAO; a link to an American Academy of Neurology report on retinal disease and loss of cognitive skills; Vistakon’s launch of its daily disposable 1-Day Acuvue Moist for Astigmatism at SECO International; and the Hawaii Optometric Association’s vote to support stand-alone plans in its state health insurance exchange.

“Our goal is to keep optometrists informed of the fast-paced changes that are buffeting the profession, and to give them the tools to adapt to those changes,” Kirkner said. “Following Optometry Times on Twitter and liking us on Facebook are just two ways optometrists can keep themselves better informed of those changes.

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.